Guarionex J. Decastro
Advanced in WT1-Related Wilms Tumor Syndromes

Dr. Guarionex J. Decastro

Urology
Columbia University Irving Medical Center
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
Offers Telehealth

Advanced in WT1-Related Wilms Tumor Syndromes
Columbia University Irving Medical Center
Trustees Of Columbia University In The City Of New York
622 W 168th St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Guarionex Decastro is an Urologist in New York, New York. Dr. Decastro is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.

His clinical research consists of co-authoring 55 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in NY
Hospital Affiliations
New York-Presbyterian Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
MVP Health
  • EPO
  • PPO
Samaritan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VNS Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
622 W 168th St, New York, NY 10032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Phase I/II Trial for the Use of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment of BCG-Refractory Non-muscle Invasive Urothelial Carcinoma of the Bladder Cancer
A Phase I/II Trial for the Use of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment of BCG-Refractory Non-muscle Invasive Urothelial Carcinoma of the Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2025
Intervention Type: Drug
Study Drugs: Cabazitaxel, Gemcitabine, Cisplatin
Study Phase: Phase 1/Phase 2
Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men
Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other
Study Phase: Phase 3
Phase 1/2 Trial Evaluating the Safety and Tolerability of NanoDoce® Injection and Intravesical Instillation in Subjects With Urothelial Carcinoma
Phase 1/2 Trial Evaluating the Safety and Tolerability of NanoDoce® Injection and Intravesical Instillation in Subjects With Urothelial Carcinoma
Enrollment Status: Completed
Publish Date: August 14, 2023
Intervention Type: Drug, Other
Study Drug: Docetaxel
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

55 Total Publications

Revisiting BCG: The potential of rescue BCG therapy for BCG-unresponsive non-muscle-invasive bladder cancer.
Revisiting BCG: The potential of rescue BCG therapy for BCG-unresponsive non-muscle-invasive bladder cancer.
Journal: Urologic oncology
Published: April 01, 2025
View All 55 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Paul S. Russo
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Paul S. Russo
Urology

Mskcc Surgery Group

353 E 68th St, 
New York, NY 
 (5.3 miles away)
646-422-4300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Paul Russo is an Urologist in New York, New York. Dr. Russo is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Reconstructive Urology Surgery.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jonathan A. Coleman
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jonathan A. Coleman
Urology

Mskcc Surgery Group

1133 York Ave, 
New York, NY 
 (5.7 miles away)
646-888-7100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jonathan Coleman is an Urologist in New York, New York. Dr. Coleman is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Prostatectomy.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Abraham A. Hakimi
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Abraham A. Hakimi
Urology

Mskcc Surgery Group

1275 York Ave, 
New York, NY 
 (5.4 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Abraham Hakimi is an Urologist in New York, New York. Dr. Hakimi is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Decastro's expertise for a condition
ConditionClose
  • Elite
  • Bladder Cancer
    Dr. Decastro is
    Elite
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Urothelial Cancer
    Dr. Decastro is
    Elite
    . Learn about Urothelial Cancer.
    See more Urothelial Cancer experts
  • Distinguished
  • Cystectomy
    Dr. Decastro is
    Distinguished
    . Learn about Cystectomy.
    See more Cystectomy experts
  • Muscle Invasive Bladder Cancer
    Dr. Decastro is
    Distinguished
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Nephrectomy
    Dr. Decastro is
    Distinguished
    . Learn about Nephrectomy.
    See more Nephrectomy experts
  • Non-Muscle Invasive Bladder Cancer
    Dr. Decastro is
    Distinguished
    . Learn about Non-Muscle Invasive Bladder Cancer.
    See more Non-Muscle Invasive Bladder Cancer experts
  • Prostate Cancer
    Dr. Decastro is
    Distinguished
    . Learn about Prostate Cancer.
    See more Prostate Cancer experts
  • Renal Cell Carcinoma (RCC)
    Dr. Decastro is
    Distinguished
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
View All 7 Distinguished Conditions
  • Advanced
  • Chromophobe Renal Cell Carcinoma
    Dr. Decastro is
    Advanced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Decastro is
    Advanced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Familial Prostate Cancer
    Dr. Decastro is
    Advanced
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Familial Wilms Tumor 2
    Dr. Decastro is
    Advanced
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Malakoplakia
    Dr. Decastro is
    Advanced
    . Learn about Malakoplakia.
    See more Malakoplakia experts
  • Prostatectomy
    Dr. Decastro is
    Advanced
    . Learn about Prostatectomy.
    See more Prostatectomy experts
View All 12 Advanced Conditions
  • Experienced
  • Bacterial Prostatitis
    Dr. Decastro is
    Experienced
    . Learn about Bacterial Prostatitis.
    See more Bacterial Prostatitis experts
  • Bilateral Hydronephrosis
    Dr. Decastro is
    Experienced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Congenital Mesoblastic Nephroma
    Dr. Decastro is
    Experienced
    . Learn about Congenital Mesoblastic Nephroma.
    See more Congenital Mesoblastic Nephroma experts
  • Empyema
    Dr. Decastro is
    Experienced
    . Learn about Empyema.
    See more Empyema experts
  • Endoscopy
    Dr. Decastro is
    Experienced
    . Learn about Endoscopy.
    See more Endoscopy experts
  • Enlarged Prostate (BPH)
    Dr. Decastro is
    Experienced
    . Learn about Enlarged Prostate (BPH).
    See more Enlarged Prostate (BPH) experts
View All 24 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved